Cancer stem cell antigens as targets for new combined anti-cancer therapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cancer stem cell antigens as targets for new combined anti-cancer therapies

Published:2020-12 Issue: Volume:129 Page:105861
ISSN:1357-2725
Container-title:The International Journal of Biochemistry & Cell Biology
language:en
Short-container-title:The International Journal of Biochemistry & Cell Biology

Author:

Quaglino Elena,Cavallo Federica,Conti Laura

Funder

Ministero della Salute

Associazione Italiana per la Ricerca sul Cancro

Fondazione Ricerca Molinette

Università degli Studi di Torino

Publisher

Elsevier BV

Subject

Cell Biology,Biochemistry

Reference83 articles.

1. PD-L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation;Almozyan;Int. J. Cancer,2017

2. Directing traffic: how to effectively drive t cells into tumors;Anandappa;Cancer Discov.,2020

3. Biological consequences of MHC-II expression by tumor cells in cancer;Axelrod;Clin. Cancer Res.,2019

4. Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma and solid tumors;Bae;Leukemia,2018

5. Glycosylation of cancer stem cells: function in stemness, tumorigenesis, and metastasis;Barkeer;Neoplasia,2018

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted immunotherapy to cancer stem cells: A novel strategy of anticancer immunotherapy;Critical Reviews in Oncology/Hematology;2024-04

2. Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy;International Journal of Molecular Sciences;2023-08-19

3. Current understanding of cancer stem cells: Immune evasion and targeted immunotherapy in gastrointestinal malignancies;Frontiers in Oncology;2023-02-23

4. The complex network of transcription factors, immune checkpoint inhibitors and stemness features in colorectal cancer: A recent update;Seminars in Cancer Biology;2023-02

5. Miscellaneous small- molecule and biological approaches to targeted cancer therapy;Medicinal Chemistry of Anticancer Drugs;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3